SIRT2 and non-small cell lung carcinoma: Further, Hoffmann et al. identified two structurally related compounds, which selectively inhibited SIRT2, AEM1, and AEM2, and both sensitized NSCLC cells to etoposide, which damages DNA by targeting topoisomerase II.